Abstract:The G protein-coupled receptor, family C, group 5, member A (GPRC5A), a retinoic acid induced gene expressed primarily in human and mouse lung tissue. Our previous studies demonstrated that mice with a deletion of the Gprc5a gene develop spontaneous lung adenomas and adenocarcinomas. Since Gprc5a is expressed preferentially in epithelial cells in lung tissues, we isolated epithelial cells from tracheas of Gprc5a+/+ and Gprc5a−/− mice and used them for an analysis of phenotypic and genotypic differences that might explain the mechanisms of Gprc5a actions. We found that normal Gprc5a−/− cells can survive better than Gprc5a+/+ cells in basal medium deprived of supplemented growth factors. Furthermore, the Gprc5a−/− cells but not the Gprc5a+/+ cells were able to form colonies in semi-solid medium. To explore possible mechanisms that underlay the distinct phenotypes of the above cells, we compared and contrasted the survival signaling pathway mediated by the Signal Transducer and Activator of Transcription 3 (STAT3), which is triggered by certain cytokines and growth factors to regulate the expression of genes implicated in cell growth differentiation, survival, inflammation and transformation. Increased Stat3 activity by phosphorylation has been identified in a variety of tumors including non-small cell lung cancers (NSCLCs) and it has been linked to inflammation and tumor progression. The constitutive activity (phosphorylation of tyrosine 705) of Stat3 and the expression of several Stat3 regulated genes including survivin, Bcl-XL, and Mcl1 at both the mRNA and protein levels was higher in the Gprc5a−/− cells compared to normal Gprc5a+/+ cells. Stat3 activation was triggered by autocrine Leukemia inhibitory factor (Lif), a member of the interleukine-6 (IL-6) family of cytokines, as revealed after adding neutralizing antibodies against different Stat3 activating cytokines to the growth medium. Although Gprc5a+/+ cells produced and secreted sufficient amounts of Lif into their conditioned medium, their response to Lif was transient, whereas the Gprc5a−/− cells showed a prolonged response evidenced by a persistent Stat3 activation. Lung cancer cells isolated from an adenocarcinorma of Gprc5a−/− mice exhibited Lif-mediated Stat3 activation similar to the normal Gprc5a−/− cells. Blocking Stat3 activation using AG490, an inhibitor of Stat3 signaling, or using a dominant negative Stat3 (mutant Y705F) in the Gprc5a−/− normal and cancer cells increased apoptosis and inhibited anchorage-independent growth. These results demonstrate that Stat3 activation may be important for the early stages of lung tumorigenesis in Gprc5a−/− mice and by implication that the tumor suppressive effects of Gprc5a are mediated, at least in part, by suppression of Stat3 signaling. Supported in part by the Samuel Waxman Cancer Research Foundation. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4995.

GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion

GPRC5A: an Emerging Biomarker in Human Cancer

Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.

The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer.

EGFR Phosphorylates and Inhibits Lung Tumor Suppressor GPRC5A in Lung Cancer.

Abstract #5347: the Lung Tumor Suppressor GPRC5A Inhibits Activation of NF-\#954;B in Human Non-Small Cell Lung Adenocarcinoma Cells

EXOSC5 Promotes Proliferation of Gastric Cancer Through Regulating AKT/STAT3 Signaling Pathways.

Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Identification of the Retinoic Acid-Inducible Gprc5a As a New Lung Tumor Suppressor Gene.

Lung Cancer Suppressor Gene GPRC5A Mediates P53 Activity in Non-Small Cell Lung Cancer Cells in Vitro

Prognostic value of <i>GPC5</i> polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients

Abstract 4995: Loss of the Lung-Specific Tumor Suppressor Gprc5a Causes Persistent Activation of Stat3 Leading to Increased Survival Signaling in Normal and Malignant Lung Epithelial Cells

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway

PDS5B inhibits cell proliferation, migration, and invasion via upregulation of LATS1 in lung cancer cells

Long noncoding RNA GAS5 inhibits angiogenesis and metastasis of colorectal cancer through the Wnt/β‐catenin signaling pathway

Regulation of GPC5 Mrna Expression by Promoter Methylation Status in Lung Adenocarcinoma

PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model

A Gprc5a Tumor Suppressor Loss of Expression Signature is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior